4//SEC Filing
Pfeiffenberger Brent 4
Accession 0001062993-23-022023
CIK 0001850119other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:07 PM ET
Size
9.0 KB
Accession
0001062993-23-022023
Insider Transaction Report
Form 4
Pfeiffenberger Brent
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-12-04+1,173,775→ 1,173,775 total - Award
Common Stock
2023-12-04+279,504→ 1,453,279 total - Award
Stock Option (right to buy)
2023-12-04+573,691→ 573,691 totalExercise: $1.61Exp: 2033-12-04→ Common Stock (573,691 underlying)
Footnotes (3)
- [F1]Reflects a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs underlying this grant shall vest 25% on December 4, 2024, with the remaining 75% vesting in one-twelfth (1/12th) increments on each of the first trading days on or after each of February 15, May 15, August 15, and November 15, subject to the Reporting Person's continued service through each applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
- [F2]Reflects a grant of RSUs. The RSUs underlying this grant shall vest in full on December 4, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- [F3]The option vests 25% on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0002001162
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:07 PM ET
- Size
- 9.0 KB